Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Charlottesville, VA
SEC filing record 1 source field available
Fiscal year end
31 December
ADIAL PHARMACEUTICALS, INC. has filed 544 SEC EDGAR filings since 16 Mar 2011

SEC filing history

Showing 201-225 of 544 matching filings.

Per page
25
Current page
9
10-K File 001-38323

ANNUAL REPORT

Filing date
30 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
DEFA14A File 001-38323

DEFINITIVE ADDITIONAL MATERIALS

Filing date
29 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
21 Mar 2023
Reporting date
15 Mar 2023
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
07 Mar 2023
Reporting date
06 Mar 2023
Next action
Verify source filing
DEF 14A File 001-38323

PROXY STATEMENT

Filing date
06 Mar 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-474990

D filing

Filing date
06 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
27 Feb 2023
Reporting date
24 Feb 2023
Next action
Verify source filing
PRE 14A File 001-38323

PRELIMINARY PROXY STATEMENT

Filing date
24 Feb 2023
Reporting date
24 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-237793

PROSPECTUS SUPPLEMENT

Filing date
24 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
24 Feb 2023
Reporting date
23 Feb 2023
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
21 Feb 2023
Reporting date
21 Feb 2023
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
01 Feb 2023
Reporting date
27 Jan 2023
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2023
Reporting date
30 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
15 Nov 2022
Reporting date
14 Nov 2022
Next action
Verify source filing
10-Q File 001-38323

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
S-8 File 333-267972

REGISTRATION STATEMENT

Filing date
21 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
13 Oct 2022
Reporting date
13 Oct 2022
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
26 Sep 2022
Reporting date
26 Sep 2022
Next action
Verify source filing
4

4 filing

Filing date
20 Sep 2022
Reporting date
19 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
14 Sep 2022
Reporting date
13 Sep 2022
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
13 Sep 2022
Reporting date
08 Sep 2022
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
06 Sep 2022
Reporting date
06 Sep 2022
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
02 Sep 2022
Reporting date
31 Aug 2022
Next action
Verify source filing
DEF 14A File 001-38323

DEFINITIVE PROXY STATEMENT

Filing date
01 Sep 2022
Reporting date
13 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .